Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Vaccinations after hematopoietic cell transplant
source: National Marrow Donor Program
year: N/A
summary/abstract:Hematopoietic cell transplant recipients may remain immunocompromised far beyond 2 years post-transplant, especially individuals with chronic graft-versus-host disease (GVHD). Therefore, post-transplant patients should be routinely revaccinated after transplant until they regain immune competence.
The vaccination schedule below is based on international consensus guidelines for preventing infectious complications among all transplant recipients and is recommended for both autologous and allogeneic hematopoietic cell transplant (HCT) recipients.
Recommended Vaccinations:
• Pneumococcal Conjugate
• Tetanus, Diphtheria, Acellular Pertussis
• Haemophilus Influenzae Conjugate
• Meningococcal Conjugate
• Inactivated Polio
• Recombinant Hepatitis B
• Inactivated Influenza
• Measles-Mumps-Rubella
read more
Related Content
-
Determining Adherence to Quality Indicators in Sickle Cell Anemia Using Multiple Data SourcesINTRODUCTION: Advances in primary prophy...
-
Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (...BACKGROUND: Immunogenicity, safety and r...
-
Kids with sickle cell disease aren’t receiving key vaccines, Michigan study findsA significant proportion of children w...
-
Randomized Trials Needed to Assess Benefits of Salmonella Vaccines in SCD Patients, Study SaysRandomized controlled trials are needed ...
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
-
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
-
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now availab...Medunik USA, a company dedicated to impr...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.